Department of Neurology, St. Olavs University Hospital, Trondheim, Norway.
Department of Neurology, St. Olavs University Hospital, Trondheim, Norway ; Department of Neurology, Norwegian University of Science and Technology, Trondheim, Norway.
J Mov Disord. 2015 Jan;8(1):33-6. doi: 10.14802/jmd.14030. Epub 2015 Jan 13.
Ataxia with vitamin E deficiency (AVED) is a rare autosomal recessive neurological disorder which usually starts in childhood. The clinical presentation is very similar to Friedreich ataxia, most patients have progressive truncal and extremity ataxia, areflexia, positive Babinski sign, dysarthria and sensory neuropathy.
We made an inquiry to our colleagues in Norway, we included information from a prevalence study published southern Norway and added data from our own known case.
A newly published prevalence study of hereditary ataxias (total of 171 subjects) found only one subject with AVED in Southeast Norway. We describe two more patients, one from the Central part and one from the Northern part of Norway. All 3 cases had age of onset in early childhood (age of 4-5 years) and all experienced gait ataxia and dysarthria. The genetic testing confirmed that they had pathogenic mutations in the α-tocopherol transfer protein gene (TTPA). All were carriers of the non-sense c.400C > T mutation, one was homozygous for that mutation and the others were compound heterozygous, either with c.358G > A or c.513_514insTT. The homozygous carrier was by far the most severely affected case.
We estimate the occurrence of AVED in Norway to be at least 0.6 per million inhabitants. We emphasize that all patients who develop ataxia in childhood should be routinely tested for AVED to make an early diagnosis for initiating treatment with high dose vitamin E to avoid severe neurological deficits.
维生素 E 缺乏伴共济失调(AVED)是一种罕见的常染色体隐性遗传性神经系统疾病,通常在儿童期发病。临床表现与弗里德里希共济失调非常相似,大多数患者有进行性躯干和四肢共济失调、反射消失、巴宾斯基征阳性、构音障碍和感觉神经病。
我们向挪威的同事进行了查询,纳入了发表在挪威南部的一项患病率研究的信息,并添加了我们自己已知病例的数据。
一项新发表的遗传性共济失调患病率研究(共 171 例患者)仅在挪威东南部发现 1 例 AVED 患者。我们描述了另外 2 例患者,1 例来自挪威中部,1 例来自挪威北部。这 3 例患者的发病年龄均在幼儿期(4-5 岁),均出现步态共济失调和构音障碍。基因检测证实他们在α-生育酚转移蛋白基因(TTPA)中存在致病性突变。所有患者均为非onsense c.400C > T 突变的携带者,1 例为该突变的纯合子,其余为复合杂合子,要么为 c.358G > A,要么为 c.513_514insTT。纯合子携带者是受影响最严重的病例。
我们估计挪威的 AVED 发生率至少为每百万居民 0.6 例。我们强调,所有在儿童期出现共济失调的患者都应常规检测 AVED,以便尽早诊断,开始用大剂量维生素 E 治疗,避免严重的神经功能缺陷。